Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2020 Jul 6;16(2):437–453. doi: 10.1007/s11481-020-09936-5

Figure 9. Synaptophysin and MAP-2 expression in the hippocampus of immunocompetent vs. immunocompromised gp120tg mice.

Figure 9.

Young (8-10 week old) and old (4-5 months old) gp120tg+ and gp120tg− mice were euthanized at 12 weeks post-LP-BM5 treatment (5×104 pfu, i.p.). Hippocampal expression of synaptophysin (A) and MAP-2 (B)at protein levels are shown here. Data are presented as mean ± SEM; n=6-10/group. Results of three-way ANOVA are shown within the graph.